Company Announcements

Seed Innovations Ltd / AIM: SEED / Sector: Closed End Investments

18 July 2025

SEED Innovations Limited

("SEED" or the "Company")

Investee Company Update: Little Green Pharma Ltd

SEED Innovations Ltd, the AIM-quoted investment company offering exposure to disruptive, high-growth, life sciences and technology ventures typically inaccessible to everyday investors, is pleased to note that its portfolio company, Little Green Pharma Ltd ("LGP"), has published its quarterly activities report and Appendix 4C for the period ending 30 June 2025 on the ASX.

SEED holds 7,324,796 ordinary shares in LGP, representing approximately 2.4% of LGP's issued share capital.

Commenting on the announcement, Alfredo Pascual, Executive Director at SEED said:

LGP has delivered another compelling quarter, achieving record cash receipts of A$12.0 million and a turnaround to a positive net operating cash inflow of A$0.5 million. This positive cash flow trend, combined with cash in bank of A$2.5 million and over A$5.0 million in unused financing facilities, enhances LGP's financial flexibility. We are particularly encouraged by the over 70% increase in Danish facility sales into Germany and over A$2.0 million in new UK purchase orders for FY26Q2 and Q3, which reinforce our confidence in LGP's strategic focus and growth trajectory in key international markets."

The following excerpt from the announcement, which was released on the ASX, is set out without any material changes.

Little Green Pharma Ltd

Quarterly Activities Report and Appendix 4C

Little Green Pharma Ltd (ASX: LGP, "LGP" or the "Company") is pleased to provide its activities report and Appendix 4C for the quarter ending 30 June 2025.

Highlights

·    Operating cashflow of $0.5 million resulting in an increase in total cash of $0.15 million

·    Revenue of $9.1 million (unaudited) up over 20% on prior corresponding period and cash receipts of $12.0 million up nearly 50% on prior corresponding period

·    31 March 2025 full year financial statements completed with a clean audit opinion; Revenue of $36.8 million (52% CAGR between FY22-FY25); Adjusted EBITDA of $2.9 million; Net Profit after Tax of $3.3 million and Net Tangible Assets of $0.24 per share

·    Danish facility sales into Germany up over 70% as German market registers record imports of 37.2 tonnes

·    First LGP branded products launched in Germany under CherryCo line New 2.4tpa room at Danish Facility commissioned giving a total capacity of 8.5tpa with another 2.4tpa room currently being fitted out

·    New laws facilitating Danish site to act as cannabis import, packing and distribution hub effective 1 January 2026 with preparations underway

·    Cash in bank of $2.5 million, up from $2.4 million in prior quarter with over $5.0 million in unused financing facilities

The announcement in full can be accessed via the following link: https://investlittlegreenpharma.com/site/investor-centre/asx-announcements

This announcement contains inside information for the purposes of Article 7 of EU Regulation No. 596/2014, which forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018 (as amended). 

- Ends -

For further information on the Company please visit: www.seedinnovations.co or contact: 

NOTES 

Seed Innovations Ltd 

Seed Innovations Ltd is an AIM quoted investment company offering exposure to disruptive, high-growth, life sciences and technology ventures typically inaccessible to everyday investors. Its strategy focuses on identifying early-stage opportunities with upcoming investment catalysts, alongside more mature investments providing near-term liquidity. With a portfolio of such investments and cash reserves, the Company is agile and poised to capitalise swiftly on new investment opportunities.

Nominated Adviser Statement

Beaumont Cornish Limited ("Beaumont Cornish"), is the Company's Nominated Adviser and is authorised and regulated in the United Kingdom by the Financial Conduct Authority. Beaumont Cornish's responsibilities as the Company's Nominated Adviser, including a responsibility to advise and guide the Company on its responsibilities under the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed solely to the London Stock Exchange. Beaumont Cornish is not acting for and will not be responsible to any other persons for providing protections afforded to customers of Beaumont Cornish nor for advising them in relation to the proposed arrangements described in the announcement or any matter referred to in it.